Ampio PharmaceuticalsAMPE

13F holders, Q4 2024 (December 31)
1holders −5
0new positions
0sold out
$0.00avg. 13F price*

At the end of Q4 2024, 1 institutions reported holding Ampio Pharmaceuticals Inc. (AMPE) in their 13F filings, down 5 from Q2 2024. 0 opened new positions and 0 sold out. The largest holder was Luminist Capital LLC ($0).

Company
Ampio Pharmaceuticals Inc.
CUSIP
03209T307
Latest filing quarter
Q1 2026

History

Number of 13F holders

0102030 Q1 2024: 28Q1 2024Q2 2024: 6Q2 2024Q4 2024: 1Q4 2024Q1 2025: 2Q1 2025Q2 2025: 3Q2 2025Q3 2025: 3Q3 2025Q4 2025: 2Q4 2025Q1 2026: 1Q1 2026

Total Exit/New Position Q2 2024 → Q4 2024

InstitutionsTotal Value
New Positions0$0
Exits0$0

Ownership 1 holders

Luminist Capital LLC 0.00% — 4 $0

"% of holder's portfolio" is AMPE's weight in each manager's 13F, not the share of Ampio Pharmaceuticals Inc. the manager owns.